BioNTech SE (BVMF:B1NT34)
Brazil flag Brazil · Delayed Price · Currency is BRL
32.79
-0.21 (-0.64%)
At close: Dec 5, 2025

BioNTech SE Revenue

BioNTech SE had revenue of 1.52B EUR in the quarter ending September 30, 2025, with 22.02% growth. This brings the company's revenue in the last twelve months to 3.15B, up 3.70% year-over-year. In the year 2024, BioNTech SE had annual revenue of 2.75B, down -27.96%.

Revenue (ttm)
3.15B EUR
Revenue Growth
+3.70%
P/S Ratio
6.35
Revenue / Employee
465.52K EUR
Employees
6,772
Market Cap
125.27B BRL

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020482.30M373.70M344.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rede D'Or São Luiz 54.20B
Raia Drogasil 42.23B
Hypera 6.97B
Fleury 8.07B
Odontoprev 2.53B
Diagnósticos da América 12.57B
Empreendimentos Pague Menos 14.27B
Blau Farmacêutica 1.77B
Revenue Rankings